chartexchange

HRMY
Harmony Biosciences Holdings, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
33.09USD+0.242%(+0.08)565,815
Pre-marketNov 18, 2026 8:49:30 AM EST
33.00USD-0.030%(-0.01)
After-hoursNov 18, 2026 4:00:30 PM EST
33.11USD+0.060%(+0.02)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Plymouth Meeting, PA, USA
Previous Close
$33.01
Beta
0.65
52-Week High
$43.49 2026-09-03
52-Week Low
$25.90 2026-02-24
SMA 50
$38.11
SMA 200
$34.51
Avg. Vol 10D
902,059
Avg. Vol 30D
1.09M
Avg. Vol 90D
964,770
Relative Vol
0.52
50.62M
0.4100%
1,691
HRMY Profile

patients are at the beginning, middle, and heart of all we do. harmony biosciences, llc, is a privately-owned biopharmaceutical company. the company was established in october 2017 with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with a focus on helping patients who live with narcolepsy. harmony biosciences is committed to advancing the understanding of narcolepsy and providing information and resources to individuals who live with, and healthcare professionals who treat, patients with narcolepsy.

HRMY Performance
PeriodPriceDateChangeBeta
1W33.802026-11-12-2.07%1.489
1M37.542026-10-19-11.83%0.850
3M39.932026-08-19-17.11%0.789
6M30.442026-05-19+8.74%0.529
1Y33.312025-11-19-0.63%0.646
2Y32.482024-11-19+1.91%—
5Y38.762021-11-19-14.60%0.779
HRMY Stock Summary

Harmony Biosciences Holdings, Inc. Common Stock (NASDAQ:HRMY) stock price today is $33.10, and today's volume is 565,815. HRMY is up 0.273% today. The 30 day average volume is 1.09M. HRMY market cap is $1.94B with 58.72M shares outstanding.